| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE | Chief Legal Officer | Restricted Stock Units | 15,510 | $484,095 | $23.41 | 03 Mar 2026 | Direct |
| Viridian Therapeutics, Inc.\DE | Chief Legal Officer | Common Stock | 3,494 | $105,029 | $30.06 | 03 Mar 2026 | Direct |
| Viridian Therapeutics, Inc.\DE | Chief Legal Officer | Stock Option (Right to Buy) | 119,300 | 02 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | 03 Mar 2026 | 1 | $0 | 4/A | Chief Legal Officer | 09 Mar 2026, 19:35 |
| VRDN | Viridian Therapeutics, Inc.\DE | 02 Mar 2026 | 5 | $0 | 4 | Chief Legal Officer | 04 Mar 2026, 19:17 |
| VRDN | Viridian Therapeutics, Inc.\DE | 31 Dec 2025 | 1 | -$70,796 | 4 | Chief Legal Officer | 02 Jan 2026, 17:25 |
| VRDN | Viridian Therapeutics, Inc.\DE | 03 Mar 2025 | 0 | $0 | 4/A | Chief Legal Officer | 04 Mar 2026, 19:10 |
| VRDN | Viridian Therapeutics, Inc.\DE | 12 Feb 2024 | 0 | $0 | 3 | Chief Legal Officer | 14 Feb 2024, 16:05 |
| VRDN | Viridian Therapeutics, Inc.\DE | 12 Feb 2024 | 1 | $0 | 4 | Chief Legal Officer | 14 Feb 2024, 16:05 |